It is particularly important in protecting the body's cells from free radical/oxidative damage
At 20 mg/mL (dose of 4 mg) the cytokine release is insignificant (35)
COX-2 selective NSAIDs (i.e., COX-2 inhibitors or coxibs) inhibit COX-2 more strongly than COX-1, resulting in less gastrointestinal side effects, but potential cardiovascular complications, most notably an increase in the risk of heart attack due to increased blood clotting propensity (see below) (Conaghan 2012)
Upadhyaya M, Han S, Consoli C, Majounie E, Horan M, Thomas NS, et al
Starting compounded semaglutide injection at $189/mo (or $149/mo on the 6-month plan) after weaning ensures access to proven, affordable treatment when safety is no longer a limiting factor
Acknowledgements The authors acknowledge the Council for Nutritional and Environmental Medicine for support throughout the study